Clinical Trial Update: CC-4047 in Treating Patients With Myelofibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of CC-4047 in patients with chronic myeloproliferative disorders and secondary myelofibrosis has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloproliferative Disorders

Drugs mentioned

• CC-4047

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Myeloproliferative Disorders, Secondary Myelofibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-09